Clostridium difficile-A continually evolving and problematic pathogen

Infection, Genetics and Evolution

Volumn 9, Issue 6, 2009, Pages 1410-1417

  Dawson, Lisa F ^a   Valiente, Esmeralda ^a   Wren, Brendan W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Clostridium difficile; Clostridium difficile infection (CDI); Comparative phylogenomics; Epidemiology; Food borne zoonotic; Pathogenicity virulence determinants; Typing methods

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; BACTERIAL DNA; VIRULENCE FACTOR;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE SEVERITY; HUMAN; INTESTINE FLORA; MICROENVIRONMENT; MOLECULAR EVOLUTION; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOTYPING; BACTERIAL GENOME; COMMUNICABLE DISEASE; CROSS INFECTION; DISEASE TRANSMISSION; DNA SEQUENCE; ECOSYSTEM; GENETICS; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PHYLOGENY; PHYSIOLOGY; PSEUDOMEMBRANOUS COLITIS; VIRULENCE;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ECOSYSTEM; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; HUMANS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; VIRULENCE; VIRULENCE FACTORS;

EID: 70449652469     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.06.005     Document Type: Note

References (101)

1. Akerlund T., Persson I., Unemo M., Noren T., Svenungsson B., Wullt M., and Burman L.G. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J. Clin. Microbiol. 46 (2008) 1530-1533
2. Arroyo L.G., Weese J.S., and Staempfli H.R. Experimental Clostridium difficile enterocolitis in foals. J. Vet. Intern. Med. 18 (2004) 734-738
3. Arroyo L.G., Staempfli H., and Weese J.S. Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea. Vet. Microbiol. 120 (2007) 179-183
4. Ausiello C.M., Cerquetti M., Fedele G., Spensieri F., Palazzo R., Nasso M., Frezza S., and Mastrantonio P. Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells. Microb. Infect. 8 (2006) 2640-2646
5. Bartlett J.G. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin. Infect. Dis. 18 Suppl. 4 (1994) S265-S272
6. Bartlett J.G. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin. Infect. Dis. 46 Suppl. 1 (2008) S4-11
7. Borriello S.P., Wren B.W., Hyde S., Seddon S.V., Sibbons P., Krishna M.M., Tabaqchali S., Manek S., and Price A.B. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect. Immun. 60 (1992) 4192-4199
8. Braun V., Hundsberger T., Leukel P., Sauerborn M., and von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 181 (1996) 29-38
9. Brazier J.S. Typing of Clostridium difficile. Clin. Microbiol. Infect. 7 (2001) 428-431
10. Brazier J.S., Raybould R., Patel B., Duckworth G., Pearson A., Charlett A., and Duerden B.I. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro. Surveill. 13 (2008) 1-5
11. Calabi E., and Fairweather N. Patterns of sequence conservation in the S-layer proteins and related sequences in Clostridium difficile. J. Bacteriol. 184 (2002) 3886-3897
12. Carter G.P., Lyras D., Allen D.L., Mackin K.E., Howarth P.M., O'Connor J.R., and Rood J.I. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J. Bacteriol. 189 (2007) 7290-7301
13. Champion O.L., Gaunt M.W., Gundogdu O., Elmi A., Witney A.A., Hinds J., Dorrell N., and Wren B.W. Comparative phylogenomics of the food-borne pathogen Campylobacter jejuni reveals genetic markers predictive of infection source. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 16043-16048
14. Dawson L.F., Stabler R.A., and Wren B.W. Assessing the role of p-cresol tolerance in Clostridium difficile. J. Med. Microbiol. 57 (2008) 745-749
15. Day Jr. W.A., Fernandez R.E., and Maurelli A.T. Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp. Infect. Immun. 69 (2001) 7471-7480
16. Delaney J.A., Dial S., Barkun A., and Suissa S. Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg. Infect. Dis. 13 (2007) 761-763
17. Deneve C., Delomenie C., Barc M.C., Collignon A., and Janoir C. Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression. J. Med. Microbiol. 57 (2008) 732-738
18. Drudy D., Calabi E., Kyne L., Sougioultzis S., Kelly E., Fairweather N., and Kelly C.P. Human antibody response to surface layer proteins in Clostridium difficile infection. FEMS Immunol. Med. Microbiol. 41 (2004) 237-242
19. Drudy D., Quinn T., O'Mahony R., Kyne L., O'Gaora P., and Fanning S. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. J. Antimicrob. Chemother. 58 (2006) 1264-1267
20. Drudy D., Harnedy N., Fanning S.A., Hannan M., and Kyne L. Emergence and control of fluoroquinolone resistant, toxin A negative, toxin B positive Clostridium difficile. Infect. Control Hosp. Epidemiol. 28 (2007) 932-940
21. Drudy D., Harnedy N., Fanning S., O'Mahony R., and Kyne L. Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland. Clin. Microbiol. Infect. 13 (2007) 298-304
22. Drudy D., Goorhuis B., Bakker D., Kyne L., van den Berg R., Fenelon L., Fanning S., and Kuijper E.J. Clindamycin-resistant clone of Clostridium difficile PCR ribotype 027. Euro. Emerg. Infect. Dis. 14 (2008) 1485-1487
23. Fawley W.N., Freeman J., Smith C., Harmanus C., van den Berg R.J., Kuijper E.J., and Wilcox M.H. Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains. J. Clin. Microbiol. 46 (2008) 954-960
24. Fenner L., Frei R., Gregory M., Dangel M., Stranden A., and Widmer A.F. Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007. Euro. J. Clin. Microbiol. Infect. Dis. 27 (2008) 1201-1207
25. Florin I., and Thelestam M. Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb. Pathog. 1 (1986) 373-385
26. Gerhard R., Nottrott S., Schoentaube J., Tatge H., Olling A., and Just I. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. J. Med. Microbiol. 57 (2008) 765-770
27. Geric B., Carman R.J., Rupnik M., Genheimer C.W., Sambol S.P., Lyerly D.M., Gerding D.N., and Johnson S. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J. Infect. Dis. 193 (2006) 1143-1150
28. Goorhuis A., Van der Kooi T., Vaessen N., Dekker F.W., Van den Berg R., Harmanus C., van den Hof S., Notermans D.W., and Kuijper E.J. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin. Infect. Dis. 45 (2007) 695-703
29. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., Bergwerff A.A., Dekker F.W., and Kuijper E.J. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47 (2008) 1162-1170
30. Hafiz S., and Oakley C.L. Clostridium difficile: isolation and characteristics. J. Med. Microbiol. 9 (1975) 129-135
31. Hammitt M.C., Bueschel D.M., Keel M.K., Glock R.D., Cuneo P., DeYoung D.W., Reggiardo C., Trinh H.T., and Songer J.G. A possible role for Clostridium difficile in the etiology of calf enteritis. Vet. Microbiol. 127 (2008) 343-352
32. Heap J.T., Pennington O.J., Cartman S.T., Carter G.P., and Minton N.P. The ClosTron: a universal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 70 (2007) 452-464
33. Hennequin C., Janoir C., Barc M.C., Collignon A., and Karjalainen T. Identification and characterization of a fibronectin-binding protein from Clostridium difficile. Microbiology 149 (2003) 2779-2787
34. Hielm S., Björkroth J., Hjjtiä E., and Korkeala H. Genomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis. Appl. Environ. Microbiol. 64 2 (1998) 703-708
35. Holt K.E., Parkhill J., Mazzoni C.J., Roumagnac P., Weill F.-X., Goodhead I., Rance R., Baker S., Maskell D.J., Wain J., Dolecek C., Achtman M., and Dougan G. High-throughput sequencing provides insights into genome variation and evolution in Salmonella typhi. Nat. Genet. 40 (2008) 987-993
36. Hussain H.A., Roberts A.P., and Mullany P. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. J. Med. Microbiol. 54 (2005) 137-141
37. Jaffe A.B., and Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21 (2005) 247-269
38. Janoir C., Pechine S., Grosdidier C., and Collignon A. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J. Bacteriol. 189 (2007) 7174-7180
39. Jhung M.A., Thompson A.D., Killgore G.E., Zukowski W.E., Songer G., Warny M., Johnson S., Gerding D.N., McDonald L.C., and Limbago B.M. Toxinotype V Clostridium difficile in humans and food animals. Emerg. Infect. Dis. 14 (2008) 1039-1045
40. Johnson S., Samore M.H., Farrow K.A., Killgore G.E., Tenover F.C., Lyras D., Rood J.I., DeGirolami P., Baltch A.L., Rafferty M.E., Pear S.M., and Gerding D.N. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N. Engl. J. Med. 341 (1999) 1645-1651
41. Jump R.L., Pultz M.J., and Donskey C.J. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?. Antimicrob. Agents. Chemother. 51 (2007) 2883-2887
42. Just I., Selzer J., Wilm M., Eichel-Streiber C.V., Mann M., and Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375 (1995) 500-503
43. Just I., Wilm M., Selzer J., Rex G., Eichel-Streiber C.V., Mann M., and Aktories K. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270 (1995) 13932-13936 10.1074/jbc.270.23.13932
44. Just I., Hofmann F., Genth H., and Gerhard R. Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins. Int. J. Med. Microbiol. 291 (2001) 243-250
45. Karlsson K.A. Microbial recognition of target-cell glycoconjugates. Curr. Opin. Struct. Biol. 5 (1995) 622-635
46. Keel K., Brazier J.S., Post K.W., Weese S., and Songer J.G. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J. Clin. Microbiol. 45 (2007) 1963-1964
47. Killgore G., Thompson A., Johnson S., Brazier J., Kuijper E., Pepin J., Frost E.H., Savelkoul P., Nicholson B., van den Berg R.J., Kato H., Sambol S.P., Zukowski W., Woods C., Limbago B., Gerding D.N., and McDonald L.C. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 46 (2008) 431-437
48. Kim H., Riley T.V., Kim M., Kim C.K., Yong D., Lee K., Chong Y., and Park J.-W. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis. J. Clin. Microbiol. 46 (2008) 1116-1117
49. Klaassen C.H., van Haren H.A., and Horrevorts A.M. Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism. J. Clin. Microbiol. 40 9 (2002) 3546-3547
50. Kuijper E.J., van Dissel J.T., and Wilcox M.H. Clostridium difficile: changing epidemiology and new treatment options. Curr. Opin. Infect. Dis. 20 (2007) 376-383
51. Kuijper E.J., and Wilcox M.H. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?. Clin. Infect. Dis. 47 (2008) 63-65
52. Larson H.E., Price A.B., Honour P., and Borriello S.P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1 (1978) 1063-1066
53. Lefebvre S.L., Waltner-Toews D., Peregrine A.S., Reid-Smith R., Hodge L., Arroyo L.G., and Weese J.S. Prevalence of zoonotic agents in dogs visiting hospitalized people in Ontario: implications for infection control. J. Hosp. Infect. 62 (2006) 458-466
54. Lemee L., Dhalluin A., Pestel-Caron M., Lemeland J.-F., and Pons J.-L. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J. Clin. Microbiol. 42 (2004) 2609-2617
55. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., Bourgault A.M., Nguyen T., Frenette C., Kelly M., Vibien A., Brassard P., Fenn S., Dewar K., Hudson T.J., Horn R., Rene P., Monczak Y., and Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353 (2005) 2442-2449
56. Lyras D., Adams V., Lucet I., and Rood J.I. The large resolvase TnpX is the only transposon-encoded protein required for transposition of the Tn4451/3 family of integrative mobilizable elements. Mol. Microbiol. 51 (2004) 1787-1800
57. MacCannell D.R., Louie T.J., Gregson D.B., Laverdiere M., Labbe A.C., Laing F., and Henwick S. Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J. Clin. Microbiol. 44 (2006) 2147-2152
58. Maiden M.C.J., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., Zhang Q., Zhou J., Zurth K., Caugant D.A., Feavers I.M., Achtman M., and Spratt B.G. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3140-3145
59. Matamouros S., England P., and Dupuy B. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol. Microbiol. 64 (2007) 1274-1288
60. Morgan O.W., Rodrigues B., Elston T., Verlander N.Q., Brown D.F., Brazier J., and Reacher M. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS ONE 3 (2008) e1812
61. O'Connor J.R., Lyras D., Farrow K.A., Adams V., Powell D.R., Hinds J., Cheung J.K., and Rood J.I. Construction and analysis of chromosomal Clostridium difficile mutants. Mol. Microbiol. 61 (2006) 1335-1351
62. Pechine S., Janoir C., and Collignon A. Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease. J. Clin. Microbiol. 43 (2005) 5018-5025
63. Pepin J., Saheb N., Coulombe M.-A., Alary M.-E., Corriveau M.-P., Authier S., Leblanc M., Rivard G., Bettez M., Primeau V., Nguyen M., Jacob C.-E., and Lanthier L. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis. 41 (2005) 1254-1260
64. Perelle S., Gibert M., Bourlioux P., Corthier G., and Popoff M.R. Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect. Immun. 65 (1997) 1402-1407
65. Pirs T., Ocepek M., and Rupnik M. Isolation of Clostridium difficile from food animals in Slovenia. J. Med. Microbiol. 57 (2008) 790-792
66. Poilane I., Fantinato C., Cruaud P., and Collignon A. Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-Rene-Muret hospitals from 2001 to 2007. Pathol. Biol. (Paris) 56 (2008) 412-416
67. Razaq N., Sambol S., Nagaro K., Zukowski W., Cheknis A., Johnson S., and Gerding D.N. Infection of hamsters with historical and epidemic BI types of Clostridium difficile. J. Infect. Dis. 196 (2007) 1813-1819
68. Reineke J., Tenzer S., Rupnik M., Koschinski A., Hasselmayer O., Schrattenholz A., Schild H., and von Eichel-Streiber C. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446 (2007) 415-419
69. Ridley A.J. Rho proteins: linking signaling with membrane trafficking. Traffic 2 (2001) 303-310
70. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L., and Donskey C.J. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis. 45 (2007) 992-998
71. Rodriguez-Palacios A., Stampfli H.R., Duffield T., Peregrine A.S., Trotz-Williams L.A., Arroyo L.G., Brazier J.S., and Weese J.S. Clostridium difficile PCR ribotypes in calves, Canada. Emerg. Infect. Dis. 12 (2006) 1730-1736
72. Rodriguez-Palacios A., Staempfli H.R., Duffield T., and Weese J.S. Clostridium difficile in retail ground meat, Canada. Emerg. Infect. Dis. 13 (2007) 485-487
73. Rupnik M., Kato N., Grabnar M., and Kato H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J. Clin. Microbiol. 41 (2003) 1118-1125
74. Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease?. Clin. Microbiol. Infect. 13 (2007) 457-459
75. Rupnik M., Widmer A., Zimmermann O., Eckert C., and Barbut F. Clostridium difficile toxinotype V, ribotype 078, in animals and humans. J. Clin. Microbiol. 46 (2008) 2146
76. Scheline R.R. Metabolism of phenolic acids by the rat intestinal microflora. Acta Pharmacol. Toxicol. (Copenh) 26 (1968) 189-205
77. Sebaihia M., Wren B.W., Mullany P., Fairweather N.F., Minton N., Stabler R., Thomson N.R., Roberts A.P., Cerdeno-Tarraga A.M., Wang H., Holden M.T., Wright A., Churcher C., Quail M.A., Baker S., Bason N., Brooks K., Chillingworth T., Cronin A., Davis P., Dowd L., Fraser A., Feltwell T., Hance Z., Holroyd S., Jagels K., Moule S., Mungall K., Price C., Rabbinowitsch E., Sharp S., Simmonds M., Stevens K., Unwin L., Whithead S., Dupuy B., Dougan G., Barrell B., and Parkhill J. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38 (2006) 779-786
78. Selmer T., and Andrei P.I. p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. Euro. J. Biochem. 268 (2001) 1363-1372
79. Settle C.D., and Wilcox M.H. Clostridium difficile and chlorine-releasing disinfectants. Lancet 371 (2008) 810
80. Shapey S., Machin K., Levi K., and Boswell T.C. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J. Hosp. Infect. 70 (2008) 136-141
81. Shin B.-M., Kuak E.Y., Yoo S.J., Shin W.C., and Yoo H.M. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea. Diagn. Microbiol. Infect. Dis. 60 (2008) 333-337
82. Shin B.M., Kuak E.Y., Yoo H.M., Kim E.C., Lee K., Kang J.O., Whang D.H., and Shin J.H. Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005. J. Med. Microbiol. 57 (2008) 697-701
83. Songer J.G., and Anderson M.A. Clostridium difficile: an important pathogen of food animals. Anaerobe 12 (2006) 1-4
84. Sorg J.A., and Sonenshein A.L. Bile salts and glycine as cogerminants for Clostridium difficile spores. J. Bacteriol. 190 (2008) 2505-2512
85. Spigaglia P., and Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J. Clin. Microbiol. 40 (2002) 3470-3475
86. Spigaglia P., Barbanti F., and Mastrantonio P. Detection of a genetic linkage between genes coding for resistance to tetracycline and erythromycin in Clostridium difficile. Microb. Drug Resist. 13 (2007) 90-95
87. Spigaglia P., Barbanti F., Mastrantonio P., Brazier J.S., Barbut F., Delmee M., Kuijper E., and Poxton I.R. Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J. Med. Microbiol. 57 (2008) 784-789
88. Stabler R.A., Gerding D.N., Songer J.G., Drudy D., Brazier J.S., Trinh H.T., Witney A.A., Hinds J., and Wren B.W. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J. Bacteriol. 188 (2006) 7297-7305
89. Stabler R.A., Dawson L.F., Phua L.T.H., and Wren B.W. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J. Med. Microbiol. 57 (2008) 771-775
90. Stubbs S.L., Brazier J.S., O'Neill G.L., and Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J. Clin. Microbiol. 37 (1999) 461-463
91. Tasteyre A., Barc M.-C., Collignon A., Boureau H., and Karjalainen T. Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect. Immun. 69 (2001) 7937-7940
92. Tucker K.D., and Wilkins T.D. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect. Immun. 59 (1991) 73-78
93. van den Hof S., van der Kooi T., van den Berg R., Kuijper E.J., and Notermans D.W. Clostridium difficile PCR ribotype 027 outbreaks in the Netherlands: recent surveillance data indicate that outbreaks are not easily controlled but interhospital transmission is limited. Euro. Surveill. 11 1 (2006) E060126 060122
94. von Eichel-Streiber C., Laufenberg-Feldmann R., Sartingen S., Schulze J., and Sauerborn M. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol. Gen. Genet. 233 (1992) 260-268
95. Vrtis M.C. Clostridium difficile: preventing epidemic outbreaks in home health. Home Healthc. Nurse 26 (2008) 563-569 quiz 570-561
96. Waligora A.-J., Hennequin C., Mullany P., Bourlioux P., Collignon A., and Karjalainen T. Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect. Immun. 69 (2001) 2144-2153
97. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., Frost E., and McDonald L.C. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 (2005) 1079-1084
98. Wheeldon L.J., Worthington T., Hilton A.C., Elliott T.S., and Lambert P.A. Physical and chemical factors influencing the germination of Clostridium difficile spores. J. Appl. Microbiol. 105 (2008) 2223-2230
99. Wilcox M.H., Fawley W.N., Wigglesworth N., Parnell P., Verity P., and Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J. Hosp. Infect. 54 (2003) 109-114
100. Yokoyama M.T., and Carlson J.R. Production of skatole and para-Cresol by a rumen Lactobacillus sp. Appl. Environ. Microbiol. 41 (1981) 71-76
101. Zidaric V., Zemljic M., Janezic S., Kocuvan A., and Rupnik M. High diversity of Clostridium difficile genotypes isolated from a single poultry farm producing replacement laying hens. Anaerobe 14 (2008) 325-327